Literature DB >> 25849208

Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.

Amir A Toor1, Roy T Sabo2, Catherine H Roberts3, Bonny L Moore3, Salman R Salman3, Allison F Scalora3, May T Aziz4, Ali S Shubar Ali3, Charles E Hall3, Jeremy Meier3, Radhika M Thorn3, Elaine Wang3, Shiyu Song5, Kristin Miller6, Kathryn Rizzo7, William B Clark3, John M McCarty3, Harold M Chung3, Masoud H Manjili8, Michael C Neale9.   

Abstract

Systems that evolve over time and follow mathematical laws as they evolve are called dynamical systems. Lymphocyte recovery and clinical outcomes in 41 allograft recipients conditioned using antithymocyte globulin (ATG) and 4.5-Gy total body irradiation were studied to determine if immune reconstitution could be described as a dynamical system. Survival, relapse, and graft-versus-host disease (GVHD) were not significantly different in 2 cohorts of patients receiving different doses of ATG. However, donor-derived CD3(+) cell reconstitution was superior in the lower ATG dose cohort, and there were fewer instances of donor lymphocyte infusion (DLI). Lymphoid recovery was plotted in each individual over time and demonstrated 1 of 3 sigmoid growth patterns: Pattern A (n = 15) had rapid growth with high lymphocyte counts, pattern B (n = 14) had slower growth with intermediate recovery, and pattern C (n = 10) had poor lymphocyte reconstitution. There was a significant association between lymphocyte recovery patterns and both the rate of change of donor-derived CD3(+) at day 30 after stem cell transplantation (SCT) and clinical outcomes. GVHD was observed more frequently with pattern A, relapse and DLI more so with pattern C, with a consequent survival advantage in patients with patterns A and B. We conclude that evaluating immune reconstitution after SCT as a dynamical system may differentiate patients at risk of adverse outcomes and allow early intervention to modulate that risk.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dynamical system; Graft-versus-host disease; Immune reconstitution; Stem cell transplant; T cells

Mesh:

Substances:

Year:  2015        PMID: 25849208      PMCID: PMC4836381          DOI: 10.1016/j.bbmt.2015.03.011

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  30 in total

1.  Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation.

Authors:  Amir A Toor; Roy T Sabo; Harold M Chung; Catherine Roberts; Rose H Manjili; Shiyu Song; David C Williams; Wendy Edmiston; Mandy L Gatesman; Richard W Edwards; Andrea Ferreira-Gonzalez; William B Clark; Michael C Neale; John M McCarty; Masoud H Manjili
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-17       Impact factor: 5.742

2.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation.

Authors:  Bipin N Savani; Stephan Mielke; Katayoun Rezvani; Aldemar Montero; Agnes S Yong; Laura Wish; Jeannine Superata; Roger Kurlander; Anurag Singh; Richard Childs; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2007-08-24       Impact factor: 5.742

Review 4.  Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.

Authors:  R A Nash; R Storb
Journal:  Curr Opin Immunol       Date:  1996-10       Impact factor: 7.486

5.  Simple mathematical models with very complicated dynamics.

Authors:  R M May
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

6.  Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation.

Authors:  Jennifer L Berrie; Maciej Kmieciak; Roy T Sabo; Catherine H Roberts; Michael O Idowu; Katherine Mallory; Harold M Chung; John M McCarty; Christian A Borrelli; Michelle M Detwiler; A Latif Kazim; Amir A Toor; Masoud H Manjili
Journal:  Transplantation       Date:  2012-05-15       Impact factor: 4.939

7.  Biological populations with nonoverlapping generations: stable points, stable cycles, and chaos.

Authors:  R M May
Journal:  Science       Date:  1974-11-15       Impact factor: 47.728

8.  Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.

Authors:  David Laurin; Dalil Hannani; Martine Pernollet; Agnès Moine; Joël Plumas; Jean-Claude Bensa; Jean-Yves Cahn; Frédéric Garban
Journal:  Transfusion       Date:  2009-10-15       Impact factor: 3.157

Review 9.  In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.

Authors:  Max Jameson-Lee; Vishal Koparde; Phil Griffith; Allison F Scalora; Juliana K Sampson; Haniya Khalid; Nihar U Sheth; Michael Batalo; Myrna G Serrano; Catherine H Roberts; Michael L Hess; Gregory A Buck; Michael C Neale; Masoud H Manjili; Amir Ahmed Toor
Journal:  Front Immunol       Date:  2014-11-06       Impact factor: 7.561

Review 10.  Stem cell transplantation as a dynamical system: are clinical outcomes deterministic?

Authors:  Amir A Toor; Jared D Kobulnicky; Salman Salman; Catherine H Roberts; Max Jameson-Lee; Jeremy Meier; Allison Scalora; Nihar Sheth; Vishal Koparde; Myrna Serrano; Gregory A Buck; William B Clark; John M McCarty; Harold M Chung; Masoud H Manjili; Roy T Sabo; Michael C Neale
Journal:  Front Immunol       Date:  2014-12-03       Impact factor: 7.561

View more
  9 in total

1.  T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.

Authors:  Jeremy A Meier; Mahdee Haque; Mohamed Fawaz; Hamdi Abdeen; David Coffey; Andrea Towlerton; Ahmed Abdeen; Abdullah Toor; Edus Warren; Jason Reed; Christopher G Kanakry; Armand Keating; Leo Luznik; Amir A Toor
Journal:  Biol Blood Marrow Transplant       Date:  2019-01-21       Impact factor: 5.742

2.  Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.

Authors:  Liwen Xu; Xiaoqing You; PingPing Zheng; Bing M Zhang; Puja K Gupta; Philip Lavori; Everett Meyer; James L Zehnder
Journal:  J Mol Diagn       Date:  2016-11-01       Impact factor: 5.568

3.  Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs.

Authors:  Badar Abdul Razzaq; Allison Scalora; Vishal N Koparde; Jeremy Meier; Musa Mahmood; Salman Salman; Max Jameson-Lee; Myrna G Serrano; Nihar Sheth; Mark Voelkner; David J Kobulnicky; Catherine H Roberts; Andrea Ferreira-Gonzalez; Masoud H Manjili; Gregory A Buck; Michael C Neale; Amir A Toor
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-11       Impact factor: 5.742

4.  Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Antithymocyte Globulin Administration Schedules in Allogeneic Stem Cell Transplantation.

Authors:  Viktoriya Zelikson; Gary Simmons; Natasha Raman; Elizabeth Krieger; Anatevka Rebiero; Kelly Hawks; May Aziz; Catherine Roberts; Alden Chesney; Jason Reed; Ronald Gress; Amir Toor
Journal:  Transplant Cell Ther       Date:  2021-10-21

5.  Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

Authors:  Matt S Zinter; Brent R Logan; Caitrin Fretham; Anil Sapru; Allistair Abraham; Mahmoud D Aljurf; Staci D Arnold; Andrew Artz; Jeffery J Auletta; Saurabh Chhabra; Edward Copelan; Christine Duncan; Robert P Gale; Eva Guinan; Peiman Hematti; Amy K Keating; David I Marks; Richard Olsson; Bipin N Savani; Celalettin Ustun; Kirsten M Williams; Marcelo C Pasquini; Christopher C Dvorak
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-26       Impact factor: 5.742

6.  Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.

Authors:  Charles E Hall; Vishal N Koparde; Maximilian Jameson-Lee; Abdelrhman G Elnasseh; Allison F Scalora; David J Kobulnicky; Myrna G Serrano; Catherine H Roberts; Gregory A Buck; Michael C Neale; Daniel E Nixon; Amir A Toor
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 7.  A Review on the Nonlinear Dynamical System Analysis of Electrocardiogram Signal.

Authors:  Suraj K Nayak; Arindam Bit; Anilesh Dey; Biswajit Mohapatra; Kunal Pal
Journal:  J Healthc Eng       Date:  2018-05-02       Impact factor: 2.682

8.  Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions.

Authors:  Elizabeth Krieger; Amir Ahmed Toor
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

9.  Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.

Authors:  Vishal Koparde; Badar Abdul Razzaq; Tara Suntum; Roy Sabo; Allison Scalora; Myrna Serrano; Max Jameson-Lee; Charles Hall; David Kobulnicky; Nihar Sheth; Juliana Feltz; Daniel Contaifer; Dayanjan Wijesinghe; Jason Reed; Catherine Roberts; Rehan Qayyum; Gregory Buck; Michael Neale; Amir Toor
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.